top of page

When The ER Sends An Addict Home: The Hidden Danger Of Treat And Street

Writer: Ryan P. Ingraham, ESQ
Ryan P. Ingraham, ESQ
Oct 21
7 min read

By Rehab Malpractice Law


The person arrives at the emergency room in crisis. They are having a seizure from alcohol withdrawal, or they have overdosed on opioids, or they are in acute intoxication that has become dangerous. The emergency department does what it does: it treats the immediate crisis. Seizure medications, oxygen, Naloxone. Fluids. Monitoring until stable.


Blue Nike sneakers step into a hospital reception area where clinicians stand at the desk.

Then the patient is discharged. A referral slip, maybe a phone number, possibly a pamphlet. Instructions to follow up with a primary care doctor or call a treatment center when they are ready.


This is called treat and street. And a growing body of clinical evidence — along with an emerging standard of care — now says it is not acceptable.



What treat and street actually costs

For a patient with a true substance use disorder, stabilizing the immediate medical crisis and sending them home does not address the underlying disease. The seizure was a symptom. The overdose was a symptom. The disorder driving both remains completely untreated when the patient walks out the door.


The consequences are predictable and documented. Patients who are discharged from emergency departments without connection to ongoing addiction treatment return to the same environments, the same triggers, and the same substances — typically within hours or days.


One specific scenario carries particularly serious medical and legal implications. Naloxone, the medication used to reverse opioid overdose, works by rapidly displacing opioids from their receptors and reversing respiratory depression. In someone who is not opioid-dependent, this is straightforwardly life-saving. In someone who is physically dependent on opioids, Naloxone can abruptly precipitate opioid withdrawal — sudden, severe, and profoundly destabilizing.


A patient in precipitated withdrawal discharged from an ER without follow-up care or medication management faces an immediate and serious risk of using again to relieve the withdrawal symptoms. Multiple overdoses in a single day become possible. Deaths have occurred this way. The Naloxone that reversed the first overdose, administered without adequate follow-up, created the conditions for the second.



The gap between treating withdrawal and treating the disorder

Emergency medicine has long drawn a distinction between treating the acute presentation and treating the underlying condition. A patient who presents with a diabetic emergency receives insulin and stabilization — but no one considers that the end of treatment for diabetes. A patient who presents after a cardiac event receives emergency intervention — and leaves the hospital with a treatment plan, follow-up appointments, and medications.


The same logic applies to addiction. Treating alcohol withdrawal with benzodiazepines or phenobarbital addresses the immediate physiological danger. It does not address alcohol use disorder. Giving Naloxone reverses an opioid overdose. It does not address opioid use disorder.


The distinction matters clinically and legally. A patient stabilized and discharged after an acute withdrawal episode carries the same underlying disease they arrived with. Without treatment for that disease, the likelihood of return to crisis is high.


A clinical presentation delivered in September 2026 at a continuing medical education webinar, "A Practical and Effective Approach to MAUD Initiation in the Emergency Department," made exactly this argument — and made the case that the emergency department visit itself should be the starting point for addiction treatment, not merely a temporary interruption in the disease's progression.



What the new standard of care actually requires

The argument being made in addiction medicine is straightforward: alcohol and opioid-related emergencies should be handled the way hospitals handle heart attacks, strokes, trauma, and sepsis. Standardized protocols. Trained staff. A clear clinical pathway. Real connection to ongoing care before the patient leaves the building.


This approach — MAUD Initiation, or Medication for Alcohol Use Disorder initiation in the emergency department — identifies specific medications that can and should be started before a patient is discharged, combined with peer support, patient navigation, and a warm handoff to addiction treatment providers.


A warm handoff is not a referral number on a discharge sheet. It is a direct connection, made while the patient is still in the facility, between the patient and a specific addiction treatment provider or peer support specialist who will follow them through the next steps. The difference in outcomes between a warm handoff and a piece of paper with a phone number is significant.




The medications available — and what each does

Three medications are FDA-approved for alcohol use disorder: naltrexone, acamprosate, and disulfiram. Their clinical profiles are different enough that they are not interchangeable, and not all are appropriate for initiation in an emergency setting.


Naltrexone is the medication most suited to ER initiation. It reduces the rewarding effect of alcohol — in plain terms, it takes some of the reinforcement out of drinking. It can reduce cravings, decrease heavy drinking days, and for some patients support abstinence. Critically, a patient does not need to complete withdrawal before starting naltrexone. It does not cause withdrawal and does not produce an adverse reaction if a patient drinks while taking it. It can be given as a daily oral medication or as a monthly injectable (Vivitrol), and the injectable form may improve adherence for patients who struggle with daily medications.


One significant safety consideration: naltrexone blocks opioid receptors. In a patient who is physically dependent on opioids, naltrexone can precipitate severe withdrawal. Any emergency department considering naltrexone initiation must assess for opioid dependence before administration. This is a clinical screening step that should be standard protocol — and its absence in a patient who is harmed represents a failure of care.


Acamprosate is primarily useful for helping patients maintain abstinence after they have stopped drinking. It works through a different mechanism than naltrexone and is taken three times daily, with potential for gastrointestinal side effects during initiation. These factors make it less practical for emergency department initiation, though it has a meaningful role in ongoing outpatient treatment.


Disulfiram works not by reducing cravings but by creating a severe adverse reaction if the patient drinks alcohol. Because patients frequently stop taking it and because of potential liver toxicity and monitoring requirements, it is generally not appropriate to initiate in an emergency setting.


Gabapentin is not FDA-approved for alcohol use disorder, but clinical evidence suggests it may reduce heavy drinking, increase abstinent days, and help with insomnia and cravings — symptoms that significantly contribute to relapse. It may be particularly useful for patients with a history of alcohol withdrawal. It carries its own risks, including dizziness, sedation, and potential for misuse, and its use requires clinical judgment rather than protocol-level initiation.



What long-term sobriety actually requires

Medication is one component. For most patients, it is not sufficient on its own.


The clinical picture of addiction recovery involves addressing whatever created vulnerability to the substance in the first place. For patients whose addiction developed through the relief pathway — using substances to manage trauma, anxiety, depression, PTSD, chronic pain, or ADHD — those underlying conditions need active treatment. Medications for AUD do not treat untreated ADHD. Naltrexone does not process unresolved trauma. The disease that lives underneath the substance use disorder requires its own attention, and treatment programs that do not assess for and address co-occurring conditions are doing incomplete work.


Recovery also requires what clinical literature calls continuing care: regular contact with treatment providers, peer support, community connection, and practical help with the social determinants of health. Housing instability, unemployment, isolation, and lack of meaningful daily structure are all predictors of relapse. Warm handoffs connect patients to this support network. Referral slips do not.


The ER visit is a moment of crisis that is also, if used correctly, a moment of openness. Research on motivation and behavior change consistently finds that people are more receptive to help in the immediate aftermath of a crisis than they are days or weeks later, when the acute discomfort has faded and the pull toward familiar patterns has strengthened. Emergency departments that fail to use that window are not simply failing to go above and beyond. They are missing a clinically significant opportunity.



When the discharge itself causes harm

Emergency departments are not treatment centers. But they are covered by the same standard of care principles that govern all medical settings: the care they provide must meet the standard a reasonably competent professional in their field would provide under similar circumstances.


As the standard of care for addiction medicine evolves to include MAUD initiation, warm handoffs, and standardized protocols for addiction-related presentations, emergency departments that continue to practice treat-and-release face increasing exposure for failing to meet that standard.


The cases that reach us at Rehab Malpractice Law are not abstract. They are patients who were discharged from emergency departments or treatment facilities without adequate monitoring, medication management, or connection to ongoing care — and who were subsequently harmed. Patients who received Naloxone without assessment for opioid dependence or follow-up planning. Patients whose withdrawal was treated without any intervention for the underlying disorder. Patients sent home with a phone number instead of a plan.


Florida's "free kill" statute adds a layer of complexity. Florida Statute 768.21 limits who can recover non-economic damages when an adult over 25 dies from medical negligence. A patient who is over 25, unmarried, and has no minor children may fall under this provision, limiting the damages available to surviving family members. This is a deeply unjust law that we fight against in every applicable case — and it does not eliminate the ability to pursue economic damages or to hold facilities accountable through other legal avenues.



What families should know

If your loved one was discharged from an emergency department or treatment facility following an overdose or withdrawal event and was subsequently harmed, the circumstances of that discharge deserve scrutiny.


Questions worth asking: Was the patient assessed for opioid dependence before Naloxone was administered? Was any medication for the underlying disorder initiated or offered before discharge? Was there a warm handoff to an addiction treatment provider, or was a referral slip the extent of the follow-up plan? Did the facility have a protocol for addiction-related presentations, and was it followed?


These questions often have answers that matter legally. And the families asking them deserve honest, informed guidance about what those answers mean.


At Rehab Malpractice Law, we investigate cases where emergency departments and treatment facilities fail the patients in their care. If your loved one was harmed after a discharge that fell below the standard of care, reach out. The first conversation is free and confidential.


📞 (561) 283-2203 


This article is for informational and educational purposes only. It does not constitute medical or legal advice and does not create an attorney-client relationship. Clinical information in this article is drawn from continuing medical education materials presented in September 2026 and is intended for general educational purposes. Patients and families should consult qualified medical and legal professionals about their specific situations.

Comments


bottom of page